Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Most users don’t clear their browser history as they will always want to find or revisit webpages long forgotten in the chaos of the World Wide Web. For multiple PC users, even with the many ...